date:Mar 20, 2018
d labelling for reducing the risks of these products.
Comments
Interested parties may, within 45 days of the publication of this notice, provide their comments on this Notice of Intent, in writing, to the Office of Legislative and Regulatory Modernization, Policy, Planning and International Affairs Directorate, Health Products and Food Branch, Department of Health, Holland Cross, Suite 14, 11 Holland Avenue, Ottawa, Ontario, K1A 0K9. Comments can also be sent by email to hc.lrm.consult